A Phase 2 Study of AZD6244 in Advanced or Metastatic Hepatocellular Carcinoma.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Selumetinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 06 May 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 06 May 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 06 May 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.